Adriaan Cleton

1.3k total citations
58 papers, 978 citations indexed

About

Adriaan Cleton is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Psychiatry and Mental health. According to data from OpenAlex, Adriaan Cleton has authored 58 papers receiving a total of 978 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 15 papers in Psychiatry and Mental health. Recurrent topics in Adriaan Cleton's work include Colorectal Cancer Treatments and Studies (15 papers), Schizophrenia research and treatment (10 papers) and Neuroscience and Neuropharmacology Research (8 papers). Adriaan Cleton is often cited by papers focused on Colorectal Cancer Treatments and Studies (15 papers), Schizophrenia research and treatment (10 papers) and Neuroscience and Neuropharmacology Research (8 papers). Adriaan Cleton collaborates with scholars based in United States, Germany and United Kingdom. Adriaan Cleton's co-authors include Mariëlle Eerdekens, Krishna Talluri, Sandra Boom, Bart Remmerie, Meindert Danhof, Stefaan Rossenu, Joris Berwaerts, Luc Janssens, David Muirhead and Rosalin Arends and has published in prestigious journals such as Journal of Clinical Oncology, Analytical Chemistry and Cancer Research.

In The Last Decade

Adriaan Cleton

57 papers receiving 931 citations

Peers

Countries citing papers authored by Adriaan Cleton

Since Specialization

Citations

This map shows the geographic impact of Adriaan Cleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adriaan Cleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adriaan Cleton more than expected).

Fields of papers citing papers by Adriaan Cleton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adriaan Cleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adriaan Cleton. The network helps show where Adriaan Cleton may publish in the future.

Co-authorship network of co-authors of Adriaan Cleton

This figure shows the co-authorship network connecting the top 25 collaborators of Adriaan Cleton. A scholar is included among the top collaborators of Adriaan Cleton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adriaan Cleton. Adriaan Cleton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	First-in-human study of a thorium-227-labeled mesothelin-targeting antibody-chelator conjugate (MSLN-TTC), in patients with malignant mesothelioma and other solid tumors 2025 ·ESMO Open ·Anna Minchom, O. Lindén, (unknown), Raffit Hassan, Frank I. Lin, (unknown), Vivek Subbiah, Agostino Tafuri, (unknown), (unknown), Adriaan Cleton, (unknown), Friedhelm Bladt, Hartwig Hennekes, Egbert F. Smit	0
2	²²⁷ Th-Labeled Anti-CD22 Antibody (BAY 1862864) in Relapsed/Refractory CD22-Positive Non-Hodgkin Lymphoma: A First-in-Human, Phase I Study 2021 ·Cancer Biotherapy and Radiopharmaceuticals ·Ola Lindén, Andrew Bates, David Cunningham, Cécilia Hindorf, (unknown), Adriaan Cleton, (unknown), (unknown), Friedhelm Bladt, Hartwig Hennekes, (unknown), Isrid Sturm, Christopher McNamara	22
3	Quantitative Dual-Isotope Planar Imaging of Thorium-227 and Radium-223 Using Defined Energy Windows 2020 ·Cancer Biotherapy and Radiopharmaceuticals ·Iain Murray, (unknown), Jonathan Gear, (unknown), Adriaan Cleton, Glenn Flux	20
4	Feasibility of Thorium-227/Radium-223 Gamma-Camera Imaging During Radionuclide Therapy 2020 ·Cancer Biotherapy and Radiopharmaceuticals ·(unknown), (unknown), Adriaan Cleton, Tomas Ohlsson, Ola Lindén, Cécilia Hindorf	13
5	The effect of gastrectomy on regorafenib exposure and progression‐free survival in patients with advanced gastrointestinal stromal tumours 2019 ·British Journal of Clinical Pharmacology ·(unknown), Winette T.A. van der Graaf, (unknown), Adriaan Cleton, George D. Demetri, Hans Gelderblom, Nielka P. van Erp	4
6	Exposure–response relationship of regorafenib efficacy in patients with hepatocellular carcinoma 2017 ·European Journal of Pharmaceutical Sciences ·Alexander Solms, (unknown), (unknown), (unknown), Henk‐Jan Drenth, Jordi Bruix, Gerold Meinhardt, Adriaan Cleton, Bart A. Ploeger	18
7	Evaluation of exposure of regorafenib and its metabolites in cancer patients with renal impairment by modelling, simulation, and clinical study 2016 ·Annals of Oncology ·Michael S. Block, Bart A. Ploeger, Joachim Grevel, Katrin Schnizler, Michael Gerisch, (unknown), (unknown), (unknown), (unknown), Isrid Sturm, Adriaan Cleton	1
8	A phase 1 study evaluating the pharmacokinetics (PK) and safety of regorafenib (REG) in patients with advanced solid tumors with severe renal impairment (SRI) 2016 ·Annals of Oncology ·Daniel J. Renouf, Hal W. Hirte, Cindy L. O’Bryant, (unknown), Adriaan Cleton, (unknown), U. Mueller, (unknown), A. Craig Lockhart, David I. Quinn, Grace K. Dy, Michael B. Sawyer	1
9	A phase I study to determine the effect of regorafenib (REG) on the pharmacokinetics (PK) of substrates of P-glycoprotein (P-gp; digoxin) and breast cancer resistant protein (BCRP; rosuvastatin) in patients with advanced solid tumors 2016 ·Annals of Oncology ·Dirk Strumberg, Salah‐Eddin Al‐Batran, István Takács, Lajos Géczi, Adriaan Cleton, (unknown), U. Mueller, (unknown), (unknown), Isrid Sturm	6
10	P-261 Pharmacokinetics of regorafenib in the phase 3 CONCUR and CORRECT trials in patients with metastatic colorectal cancer (mCRC) 2015 ·Annals of Oncology ·Adriaan Cleton, Isrid Sturm, (unknown), Joachim Grevel, (unknown), John Lettieri	1
11	A time scaling approach to develop an in vitro–in vivo correlation (IVIVC) model using a convolution-based technique 2011 ·Journal of Pharmacokinetics and Pharmacodynamics ·(unknown), Stefaan Rossenu, An Vermeulen, Adriaan Cleton, Adrian Dunne	10
12	A nonlinear mixed effects IVIVC model for multi-release drug delivery systems 2008 ·Journal of Pharmacokinetics and Pharmacodynamics ·Stefaan Rossenu, (unknown), An Vermeulen, Adriaan Cleton, A. Dunne	10
13	No pharmacokinetic interaction between trimethoprim and paliperidone ER in healthy subjects 2006 ·Biological Psychiatry ·Adriaan Cleton, Krishna Talluri, Ann Mertens, (unknown), Luc Janssens, Mariëlle Eerdekens, Sandra Boom	2
14	A pharmacokinetic model to document the interconversion between the enantiomers of paliperidone 2006 ·Biological Psychiatry ·Stefaan Rossenu, An Vermeulen, Adriaan Cleton, Krishna Talluri, Ann Mertens, Luc Janssens, Sandra Boom	3
15	Evaluation of the human serum albumin column as a discovery screening tool for plasma protein binding 2002 ·European Journal of Pharmaceutical Sciences ·(unknown), (unknown), (unknown), Adriaan Cleton, Joanne Brodfuehrer, Lucinda H. Cohen	25
16	Mechanism-Based Modeling of Functional Adaptation Upon Chronic Treatment with Midazolam 2000 ·Pharmaceutical Research ·Adriaan Cleton, (unknown), (unknown), Wim E. J. M. Ghijsen, Rob A. Voskuyl, Meindert Danhof	11
17	Mechanism-Based Modeling of Adaptive Changes in the Pharmacodynamics of Midazolam in the Kindling Model of Epilepsy 1999 ·Pharmaceutical Research ·Adriaan Cleton, (unknown), Wim E. J. M. Ghijsen, Rob A. Voskuyl, Meindert Danhof	8
18	Application of a Combined “Effect Compartment/Indirect Response Model” to the Central Nervous System Effects of Tiagabine in the Rat 1999 ·Journal of Pharmacokinetics and Biopharmaceutics ·Adriaan Cleton, (unknown), Peter M. Edelbroek, R.A. Voskuyl, Meindert Danhof	27
19	Rate of change of blood concentrations is a major determinant of the pharmacodynamics of midazolam in rats 1999 ·British Journal of Pharmacology ·Adriaan Cleton, (unknown), R.A. Voskuyl, Meindert Danhof	16
20	Liquid chromatographic determination of the adenosine receptor agonist CGS 21680 in blood using on-line solid-phase extraction on a phenylboronic acid support and fluorescence detection 1994 ·Journal of Chromatography B Biomedical Sciences and Applications ·Hubertus Irth, Adriaan Cleton, Ron A. A. Mathôt, Meindert Danhof, Adriaan P. IJzerman, U.R. Tjaden, J. van der Greef	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact